Centrient Pharmaceuticals International B.V.
besloten vennootschap met beperkte aansprakelijkheid (BV) · Delft, Netherlands · LEI 724500434G5NOB9RL660
LEI active
Summary
Centrient Pharmaceuticals International B.V. is registered in the Netherlands and entered in the “Business Register (KvK)” under number 35008465. Its legal form is besloten vennootschap met beperkte aansprakelijkheid (BV) – private limited company (Netherlands). According to GLEIF, its direct parent is Centrient Holding B.V. (Netherlands). GLEIF gives this reason: the parent has no LEI and has not consented to obtain one. It has 1 direct subsidiary in GLEIF data. The LEI was first issued on 20 Dec 2017 and the record was last updated on 20 Dec 2025; the next renewal is due by 20 Dec 2026.
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
No data-quality notes for this entity in this data release.
Company details
| Legal form | besloten vennootschap met beperkte aansprakelijkheid (BV) private limited company (Netherlands) |
|---|---|
| Register | Business Register (KvK) · Register website |
| Registration number | 35008465 |
| Registration authority | The Netherlands Chamber of Commerce |
| Jurisdiction | Netherlands |
| Registered address | Alexander Fleminglaan 1, 2613AX Delft, Netherlands |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 12 Jan 1962 |
| LEI | 724500434G5NOB9RL660 |
| LEI status | active |
| LEI first issued | 20 Dec 2017 |
| LEI record last updated | 20 Dec 2025 |
| Next LEI renewal | 20 Dec 2026 |
| Corroboration of the LEI record | fully corroborated |
Group membership
Centrient Pharmaceuticals International B.V. this entity
Centrient Pharmaceuticals Netherlands B.V. Netherlands
Relationship to the parent
| Direct parent | |
|---|---|
| Parent | Centrient Holding B.V. |
| Accounting period | 1 Jan 2024 to 31 Dec 2024 |
| Evidence | consolidated accounts |
| Corroboration | supplied by the entity only |
| Accounting standard | IFRS |
| Consolidation percentage reported to GLEIF | 100.00% |
| Relationship start | 14 Jun 2018 |
| Recorded at GLEIF since | 27 Oct 2022 |
| Last updated | 20 Dec 2025 |
| Record status | current |
Parent not reported to GLEIF
- Ultimate parent: the parent has no LEI and has not consented to obtain one.
Direct subsidiaries (1)
- Centrient Pharmaceuticals Netherlands B.V. Netherlands · Delft